NeuPath Health Inc Capital Reinvestment Ratio
NeuPath Health Inc capital reinvestment ratio. NeuPath Health Inc (NPTH) has a Capital Reinvestment Ratio of 0.31x as of June 2026, meaning it reinvests 0% of its operating cash flow (CA$906.00K) in capital expenditures (CA$281.00K). Check NPTH cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of NeuPath Health Inc (2021–2025)
Capital reinvestment ratio of NeuPath Health Inc from 2021 to 2025. This chart tracks NeuPath Health Inc's Capital Reinvestment Ratio across 5 annual periods. Also explore NPTH year-over-year net asset growth to track the company's year-over-year net asset growth rate.
NeuPath Health Inc Capital Reinvestment Ratio by Year (2021–2025)
NeuPath Health Inc capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see NPTH operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CA$4.00 Million | CA$863.00K | ▼ -40.7% |
| 2024 | 0.36x | CA$2.61 Million | CA$948.00K | ▲ +212.1% |
| 2023 | 0.12x | CA$3.03 Million | CA$353.00K | ▼ -93.0% |
| 2022 | 1.67x | CA$738.00K | CA$1.23 Million | ▲ +679.4% |
| 2021 | 0.21x | CA$1.92 Million | CA$411.00K | — |